|
[Related PubMed/MEDLINE] Total Number of Papers: 9
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2019 |
A dose titration study of fentanyl buccal soluble film for breakthrough cancer pain in Taiwan. |
AEs, BTP, PP, SAEs |
2 |
2018 |
Proportional dose of rapid-onset opioid in breakthrough cancer pain management: An open-label, multicenter study. |
AEs, BTP |
3 |
2012 |
Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects : A Phase I, Open-Label, Three-Period, Crossover Study. |
AUC |
4 |
2012 |
Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover study. |
AUC |
5 |
2011 |
Absorption and tolerability of fentanyl buccal soluble film (FBSF) in patients with cancer in the presence of oral mucositis. |
--- |
6 |
2010 |
Efficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update. |
--- |
7 |
2010 |
Evaluation of the single- and multiple-dose pharmacokinetics of fentanyl buccal soluble film in normal healthy volunteers. |
--- |
8 |
2010 |
Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study. |
AEs, SPID30 |
9 |
2009 |
Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study. |
BEMA, OTFC, tmax |
|